These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32440782)

  • 21. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
    Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Process Induced Disorder in Milled Samples Using Different Analytical Techniques.
    Zimper U; Aaltonen J; McGoverin CM; Gordon KC; Krauel-Goellner K; Rades T
    Pharmaceutics; 2010 Feb; 2(1):30-49. PubMed ID: 27721341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-state vitrification of crystalline griseofulvin by mechanical milling.
    Willart JF; Carpentier L; Danède F; Descamps M
    J Pharm Sci; 2012 Apr; 101(4):1570-7. PubMed ID: 22252982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystalline Polymorphism Emerging From a Milling-Induced Amorphous Form: The Case of Chlorhexidine Dihydrochloride.
    Elisei E; Willart JF; Danède F; Siepmann J; Siepmann F; Descamps M
    J Pharm Sci; 2018 Jan; 107(1):121-126. PubMed ID: 28716502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
    Kumar S; Burgess DJ
    Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Dudognon E; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2016 Feb; 499(1-2):67-73. PubMed ID: 26707413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
    Balani PN; Ng WK; Tan RB; Chan SY
    J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S; Ghoroi C
    Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Milling to Explore Physical States: The Amorphous and Polymorphic Forms of Sulindac.
    Latreche M; Willart JF; Guerain M; Hédoux A; Danède F
    J Pharm Sci; 2019 Aug; 108(8):2635-2642. PubMed ID: 30905700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of wet milling process on the solid state of indomethacin and simvastatin.
    Sharma P; Denny WA; Garg S
    Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of milling-induced disorder of two pharmaceutical compounds.
    Otte A; Carvajal MT
    J Pharm Sci; 2011 May; 100(5):1793-804. PubMed ID: 21374615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of solid dispersion of simvastatin.
    Silva TD; Arantes VT; Resende JA; Speziali NL; de Oliveira RB; Vianna-Soares CD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1348-55. PubMed ID: 20545512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural evolution of indomethacin particles upon milling: time-resolved quantification and localization of disordered structure studied by IGC and DSC.
    Planinsek O; Zadnik J; Kunaver M; Srcic S; Godec A
    J Pharm Sci; 2010 Apr; 99(4):1968-81. PubMed ID: 20049752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M
    Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.